In order to be eligible to participate in this study, an individual must meet all of the following criteria: - Any individual >=18 years of age who is enrolled in 14-AA-0181 and is seeking inpatient treatment. - Vibration Controlled Elastography parameters with initial CAP of >295dB/m.

An individual who meets any of the following criteria will be excluded from participation in this study: - Pregnancy - Existing diagnosis of hyperlipidemia or essential hypertension - Hemoglobin A1c >= 6.5% - Waist to hip ratio: >=0.90 in males, >=0.85 in females - Existing use of cholesterol lowering medications including statins, fibrates, or other similar medications used for the purposes of treating hyperlipidemia. - Those with evidence of severe alcoholic hepatitis with a Maddrey s Discriminant Function > 32 - Those with other chronic liver diseases including chronic hepatitis B (positive hepatitis B surface Ag on admission), hepatitis C (positive hepatitis C RNA), or autoimmune hepatitis (clinical diagnosis based on high titer of positive ANA and or anti smooth muscle Ab and a history of autoimmune disease) - HIV infection - Contraindication or inability to perform a liver biopsy. - Participants with coagulopathy (PT/PTT values that are prolonged (Bullet) 3 seconds from the upper limit of the normal, including treatment with oral and parenteral anticoagulants), thrombocytopenia (< 70,000), abnormal bleeding time or platelet dysfunction. Antiplatelet agents taken for cardiovascular prevention will not exclude participants, unless they cannot be stopped safely for the performance of a liver biopsy. - Hemoglobin level < 11 g/dL - Inability to provide informed consent.